Position in NVO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$21,764
+$5,080 QoQ
Shares Held
454
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,181
of 1,348 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026POM Investment Strategies, LLC holds $642,919 across 10 Drug Manufacturers - General names. NVO ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,492 | $375,446 | |
| 2 | PFE |
Pfizer Inc
|
3,000 | $72,240 | |
| 3 | MRK |
Merck & Co., Inc.
|
541 | $69,518 | |
| 4 | LLY |
ELI LILLY & Co
|
48 | $57,572 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
513 | $29,559 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
454 | $21,764 | |
| 7 | JNJ |
Johnson & Johnson
|
37 | $9,396 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
36 | $4,548 |
All Filings in NVO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,764 | 454 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $16,684 | 454 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $23,099 | 454 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,412 | 494 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,095 | 494 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $34,303 | 494 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $42,493 | 494 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $58,820 | 494 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $64,803 | 454 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $58,293 | 454 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $46,966 | 454 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||